Cargando…

Changes in the digital health landscape in cardiac electrophysiology: A pre-and peri-pandemic COVID-19 era survey

BACKGROUND: Digital health is transforming healthcare delivery. OBJECTIVE: To compare the current digital health landscape in select groups of cardiac electrophysiology (EP) professionals prior to and during the COVID-19 era. METHODS: Two online surveys were emailed to 4 Heart Rhythm Society communi...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Janet K., Al-Khatib, Sana M., Albert, Christine M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890346/
https://www.ncbi.nlm.nih.gov/pubmed/35265890
http://dx.doi.org/10.1016/j.cvdhj.2020.12.001
Descripción
Sumario:BACKGROUND: Digital health is transforming healthcare delivery. OBJECTIVE: To compare the current digital health landscape in select groups of cardiac electrophysiology (EP) professionals prior to and during the COVID-19 era. METHODS: Two online surveys were emailed to 4 Heart Rhythm Society communities and tweeted out to Twitter EP, 1 before and 1 during the pandemic. Categorical variables were analyzed using the χ(2) test and reported as absolute numbers and percentages. RESULTS: There were 253 pre-pandemic (S1) and 273 follow-up surveys (S2) completed. The majority of respondents to both surveys were male, aged <55 years (70.6% vs 75.1%), university-affiliated (52.6% vs 55%), and physicians (83.3% vs 87.9%). Between S1 and S2, routine use of video-telehealth increased (5.9% vs 58.6%; P < .001) for all types of consultations (P < .001 for all). Wireless electrocardiogram prescribing was prevalent and similar (80.2% vs 81.0%), whereas wireless blood pressure monitoring (9.9% vs 18.3%) and wireless oximetry (1.6% vs 8.1%; P = .006 for both) prescribing both increased. For smartphone mobile applications (mApps), prescriptions for heart rate mApps decreased (50.6% vs 40.7%; P = .022), while vital sign (28.9% vs 37%; P = .04) and symptom trackers (15.8% vs 24.9%; P = .01) prescribing increased. A majority in both surveys (84.6% vs 75.5%) reported no workplace infrastructure or support for digital health with concerns for lack of parity in reimbursement. CONCLUSION: Our results show an increase in adoption of digital health by EP during the COVID-19 pandemic. Concerns regarding a lack of supportive infrastructure persisted. Development of professional society guidelines on optimal clinical workflow, infrastructure, and reimbursement may help advance and sustain digital health integration in EP.